RNF111 and breast carcinoma: Other studies have shown that the expression of circ-RNF111 is increased in paclitaxel-resistant tissues and cells, and knocking out circ-RNF111 reduces paclitaxel’s effectiveness on breast cancer cells (Liang et al., 2019).